Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.
Study Type
OBSERVATIONAL
Enrollment
477
Hospital de Orihuela
Orihuela, Alicante, Spain
Hospital Clínico Universitario de San Juan
Sant Joan d'Alacant, Alicante, Spain
Hospital Marina Baixa
Villajoyosa, Alicante, Spain
Hospital German Trias i Pujol
Badalona, Barcelona, Spain
Hospital General de Castellón
Castellon, Castellón, Spain
Hospital de La Linea
La Línea de la Concepción, Cádiz, Spain
Hospital Universitario de Donostia
San Sebastián, Guipúzcua, Spain
Hospital Universitario A Coruña
A Coruña, La Coruña, Spain
Hospital de San Pedro
Logroño, La Rioja, Spain
Hospital de Santa Lucía
Cartagena, Murcia, Spain
...and 20 more locations
Overall survival
Overall survival after HCC diagnosis at 1 year
Time frame: At 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.